151 related articles for article (PubMed ID: 9066353)
1. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K
Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
[TBL] [Abstract][Full Text] [Related]
2. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
Calabresi PA; Tranquill LR; Dambrosia JM; Stone LA; Maloni H; Bash CN; Frank JA; McFarland HF
Ann Neurol; 1997 May; 41(5):669-74. PubMed ID: 9153530
[TBL] [Abstract][Full Text] [Related]
3. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging.
Hartung HP; Reiners K; Archelos JJ; Michels M; Seeldrayers P; Heidenreich F; Pflughaupt KW; Toyka KV
Ann Neurol; 1995 Aug; 38(2):186-93. PubMed ID: 7544573
[TBL] [Abstract][Full Text] [Related]
4. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis.
Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K
Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670
[TBL] [Abstract][Full Text] [Related]
5. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
[TBL] [Abstract][Full Text] [Related]
6. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson AJ; Miller DH; Feldmann M; Thompson EJ
Neurology; 1997 Jun; 48(6):1557-65. PubMed ID: 9191766
[TBL] [Abstract][Full Text] [Related]
8. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
9. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients.
Kahraman S; Yilmaz R; Kirkpantur A; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Nephrology (Carlton); 2005 Jun; 10(3):264-9. PubMed ID: 15958039
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis.
Airas L; Mikkola J; Vainio JM; Elovaara I; Smith DJ
J Neuroimmunol; 2006 Aug; 177(1-2):132-5. PubMed ID: 16806498
[TBL] [Abstract][Full Text] [Related]
11. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
12. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
Narayana PA; Doyle TJ; Lai D; Wolinsky JS
Ann Neurol; 1998 Jan; 43(1):56-71. PubMed ID: 9450769
[TBL] [Abstract][Full Text] [Related]
13. Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis.
Ukkonen M; Wu K; Reipert B; Dastidar P; Elovaara I
Mult Scler; 2007 Jul; 13(6):701-7. PubMed ID: 17613596
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
Ann Neurol; 1993 Jun; 33(6):646-9. PubMed ID: 8098933
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction.
Zeitler H; Ko Y; Zimmermann C; Nickenig G; Glänzer K; Walger P; Sachinidis A; Vetter H
Eur J Med Res; 1997 Sep; 2(9):389-94. PubMed ID: 9300936
[TBL] [Abstract][Full Text] [Related]
17. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus.
Kawamura T; Umemura T; Kanai A; Nagashima M; Nakamura N; Uno T; Nakayama M; Sano T; Hamada Y; Nakamura J; Hotta N
Metabolism; 2006 Apr; 55(4):461-6. PubMed ID: 16546476
[TBL] [Abstract][Full Text] [Related]
18. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
[TBL] [Abstract][Full Text] [Related]
19. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
20. Soluble adhesion molecules in acute disseminated encephalomyelitis.
Martino D; Branson JA; Church AJ; Candler PM; Livrea P; Giovannoni G; Dale RC
Pediatr Neurol; 2005 Oct; 33(4):255-8. PubMed ID: 16194723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
